Cargando…

miRNA: A Promising Therapeutic Target in Cancer

microRNAs are small non-coding RNAs that regulate several genes post-transcriptionally by complementarity pairing. Since discovery, they have been reported to be involved in a variety of biological functions and pathologies including cancer. In cancer, they can act as a tumor suppressor or oncomiR d...

Descripción completa

Detalles Bibliográficos
Autores principales: Menon, Amrutha, Abd-Aziz, Noraini, Khalid, Kanwal, Poh, Chit Laa, Naidu, Rakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569513/
https://www.ncbi.nlm.nih.gov/pubmed/36232799
http://dx.doi.org/10.3390/ijms231911502
_version_ 1784809872632578048
author Menon, Amrutha
Abd-Aziz, Noraini
Khalid, Kanwal
Poh, Chit Laa
Naidu, Rakesh
author_facet Menon, Amrutha
Abd-Aziz, Noraini
Khalid, Kanwal
Poh, Chit Laa
Naidu, Rakesh
author_sort Menon, Amrutha
collection PubMed
description microRNAs are small non-coding RNAs that regulate several genes post-transcriptionally by complementarity pairing. Since discovery, they have been reported to be involved in a variety of biological functions and pathologies including cancer. In cancer, they can act as a tumor suppressor or oncomiR depending on the cell type. Studies have shown that miRNA-based therapy, either by inhibiting an oncomiR or by inducing a tumor suppressor, is effective in cancer treatment. This review focusses on the role of miRNA in cancer, therapeutic approaches with miRNAs and how they can be effectively delivered into a system. We have also summarized the patents and clinical trials in progress for miRNA therapy.
format Online
Article
Text
id pubmed-9569513
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95695132022-10-17 miRNA: A Promising Therapeutic Target in Cancer Menon, Amrutha Abd-Aziz, Noraini Khalid, Kanwal Poh, Chit Laa Naidu, Rakesh Int J Mol Sci Review microRNAs are small non-coding RNAs that regulate several genes post-transcriptionally by complementarity pairing. Since discovery, they have been reported to be involved in a variety of biological functions and pathologies including cancer. In cancer, they can act as a tumor suppressor or oncomiR depending on the cell type. Studies have shown that miRNA-based therapy, either by inhibiting an oncomiR or by inducing a tumor suppressor, is effective in cancer treatment. This review focusses on the role of miRNA in cancer, therapeutic approaches with miRNAs and how they can be effectively delivered into a system. We have also summarized the patents and clinical trials in progress for miRNA therapy. MDPI 2022-09-29 /pmc/articles/PMC9569513/ /pubmed/36232799 http://dx.doi.org/10.3390/ijms231911502 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Menon, Amrutha
Abd-Aziz, Noraini
Khalid, Kanwal
Poh, Chit Laa
Naidu, Rakesh
miRNA: A Promising Therapeutic Target in Cancer
title miRNA: A Promising Therapeutic Target in Cancer
title_full miRNA: A Promising Therapeutic Target in Cancer
title_fullStr miRNA: A Promising Therapeutic Target in Cancer
title_full_unstemmed miRNA: A Promising Therapeutic Target in Cancer
title_short miRNA: A Promising Therapeutic Target in Cancer
title_sort mirna: a promising therapeutic target in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569513/
https://www.ncbi.nlm.nih.gov/pubmed/36232799
http://dx.doi.org/10.3390/ijms231911502
work_keys_str_mv AT menonamrutha mirnaapromisingtherapeutictargetincancer
AT abdaziznoraini mirnaapromisingtherapeutictargetincancer
AT khalidkanwal mirnaapromisingtherapeutictargetincancer
AT pohchitlaa mirnaapromisingtherapeutictargetincancer
AT naidurakesh mirnaapromisingtherapeutictargetincancer